CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new antibacterial agents by creating chimeric conjugates of pyocin S2, a natural protein, and synthetic antibiotics. The goal is to effectively target and kill Pseudomonas aeruginosa, a major cause of infections in vulnerable patients, by utilizing the bacteriocin's unique properties…
Bacterial antibiotic resistance has become a massive threat to the public health.
The situation with the opportunistic pathogen P.aeruginosa is particularly worrying because this major cause of nosocomial infections in immunocompromised patients becomes resistant to nearly all antibiotics available.
Pyocin S2 is a bacteriocin, a natural protein able to kill several P.aeruginosa strains.
The pyocin highjacks a nutrient transport system of the bacteria to get across the cell envelop.
My project ai…
UNIVERSITE DE STRASBOURG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
